We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
PVLA icon
101
Palvella Therapeutics
PVLA
$1.83B
$1.83B $127.34 3.88%
MESO icon
102
Mesoblast
MESO
$1.81B
$1.81B $13.95 1.16%
URGN icon
103
UroGen Pharma
URGN
$1.79B
$1.79B $36.61 0.08%
XNCR icon
104
Xencor
XNCR
$1.78B
$1.78B $24 2.61%
VIR icon
105
Vir Biotechnology
VIR
$1.77B
$1.77B $10.47 0.58%
BRVE
106
Braveheart Bio
BRVE
$1.76B
$1.76B $19.55 1.09%
SEPN icon
107
Septerna Inc
SEPN
$1.75B
$1.75B $37.45 3.11%
BHVN icon
108
Biohaven
BHVN
$1.73B
$1.73B $11.43 4.57%
TRVI icon
109
Trevi Therapeutics
TRVI
$1.73B
$1.73B $12.11 0.41%
GENB icon
110
Generate Biomedicines
GENB
$1.68B
$1.68B $13.06 4.31%
NUVB icon
111
Nuvation Bio
NUVB
$1.67B
$1.67B $4.75 1.5%
ZBIO icon
112
Zenas BioPharma
ZBIO
$1.66B
$1.66B $25.40 2.17%
OCUL icon
113
Ocular Therapeutix
OCUL
$1.62B
$1.62B $7.38 2.5%
NTLA icon
114
Intellia Therapeutics
NTLA
$1.59B
$1.59B $11.34 0.79%
STOK icon
115
Stoke Therapeutics
STOK
$1.59B
$1.59B $24.61 5.8%
GPCR icon
116
Structure Therapeutics
GPCR
$1.58B
$1.58B $22.19 1.42%
QURE icon
117
uniQure
QURE
$1.56B
$1.56B $22.52 7.39%
KRSA
118
Korsana Biosciences, Inc. Common Stock
KRSA
$1.53B
$1.53B $33.65 1.95%
MAZE icon
119
Maze Therapeutics
MAZE
$1.53B
$1.53B $27.48 4.77%
ABSI icon
120
Absci
ABSI
$1.52B
$1.52B $8.88 1.6%
COAG icon
121
Hemab Therapeutics
COAG
$1.52B
$1.52B $32.52 8.62%
IMCR icon
122
Immunocore
IMCR
$1.52B
$1.52B $29.48 4.02%
KLRA icon
123
Kailera Therapeutics
KLRA
$1.52B
$1.52B $11.71 9.03%
INVA icon
124
Innoviva
INVA
$1.51B
$1.51B $20.86 0.52%
RARE icon
125
Ultragenyx Pharmaceutical
RARE
$1.5B
$1.5B $15.17 1.81%
3 4
5
6 7

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 568 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.25T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $129B, Moderna (MRNA) at $94.4B and Regeneron Pharmaceuticals (REGN) at $82B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.